Basisbank Offers Customers a New Mobile Bank – A Fast, Convenient, and Modern Digital Experience
As part of its ongoing development of remote services, Basisbank has introduced a completely new Mobile Bank to its customers. The new application offers users a significantly simplified, secure, and multi-functional digital environment, making daily banking services even more convenient and accessible.
The new Mobile Bank is designed with a sophisticated interface and intuitive navigation. This allows customers to receive banking products and services that are individually tailored to them, in accordance with modern digital trends.
The new Mobile Bank enables users to:
“The new Mobile Bank was developed entirely in-house, guided by our customers' feedback and expectations. We have significantly simplified processes and enhanced the overall digital user experience. Because the development of remote banking is both a continuous process and a key strategic priority for Basisbank, our team is committed to continuously rolling out new innovations, enabling our customers to access new products and services remotely," said Khatia Shaverdashvili, Basisbank's Mobile and Internet Banking Product Owner.
Download the new Mobile Bank and register in just a few seconds.
For additional information, please call us on *9292 or contact us via direct message.
Top 10
Other News
EBRD promotes domestic production of pharmaceuticals in Uzbekistan
08.01.2026.17:08
The European Bank for Reconstruction and Development (EBRD) is promoting further growth in domestic production of pharmaceutical products in Uzbekistan by supporting the operations of leading local manufacturer Nika Pharm.
Nika Pharm will use the EBRD loan of up to US$ 20 million to restructure its balance sheet and upgrade equipment and facilities in order to increase production capacity, improve product quality and bring the entire manufacturing process into compliance with the Good Manufacturing Practice (GMP) standards of the World Health Organisation’s certification scheme.
The company has been an EBRD client since 2021 and is a well-established producer of tablets, capsules, sachets and nasal sprays for use in the treatment of common colds, as well as in gastroenterology, paediatrics and urology. During this time, Nika Pharm has become a leader in several key segments, including decongestants, and has shown strong and sustainable growth by replacing imports with high-quality local production.
The project will help to expand Nika Pharm’s manufacturing base, improve its sustainability and efficiency, and lead to an average 140 per cent increase in the company’s production of generic pharmaceuticals and prescription drugs. Together with GMP certification, this will allow Nika Pharm to strengthen its position both domestically and regionally.
Uzbekistan’s rapidly growing pharmaceuticals market, which is set to expand by a further 10 per cent by 2029, is dominated (around 75 per cent) by imported medicines. The project will help contribute to the government’s plan of eventually bringing the share of locally produced pharmaceuticals to 80 per cent.
The EBRD has invested over US$ 6.6 billion in Uzbekistan to date through 196 projects, with the majority of those funds supporting private entrepreneurship, contributing to the country’s economic development.
Levan Kobakhidze has been appointed as Bank of Georgia's new Head of Payments business
05.01.2026.04:59
ADB Governors Agree to Amend Bank Charter, Opening Path to 50% Expansion of Operations
17.11.2025.17:00
Geosky Airlines Continues Fleet Expansion – the Fourth Boeing 767-300F Has Arrived in Tbilisi
06.11.2025.12:02
